{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:04:11Z","timestamp":1792011851860,"version":"4.4.0"},"reference-count":53,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2023-0017_abs_001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Minimal Access Surgery (MAS) has shown better peri-operative outcomes with equivalent oncological outcomes in gastrointestinal and thoracic oncology. Open CRS (O-CRS) procedure accompanies inevitable and significant surgical morbidity in patients. The aim of the review article is to compare outcomes of M-CRS and HIPEC\/EPIC with open procedure in peritoneal surface malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2023-0017_abs_002\">\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>Comprehensive search of databases was done and total 2,807 articles were found (2793-PubMed and 14-Cochrane review). PRISMA flow chart was prepared and 14 articles were selected. Meta-analysis was performed according to PRISMA guidelines using random-effects model (DerSimonian Laird) and fixed effect model. Publication bias was tested with Funnel plot and Egger\u2019s regression test. Quality of studies was assessed by Newcastle\u2013Ottawa scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2023-0017_abs_003\">\n                    <jats:title>Summary and Outlook<\/jats:title>\n                    <jats:p>Patients in both groups [total (732), M-CRS(319), O-CRS(413)] were similar in demographic characteristics. Peri-operative outcomes were significantly better in M-CRS group in terms of blood loss SMD=\u22122.379, p&lt;0.001 (95\u202f%\u00a0CI\u00a0\u22122.952 to\u00a0\u22121.805), blood transfusion RR=0.598, p=0.011 (95\u202f% CI 0.402 to 0.889), bowel recovery SMD=\u22120.843, p=0.01 (95\u202f% CI\u00a0\u22121.487 to\u00a0\u22120.2), hospital stay SMD=\u22122.348, p&lt;0.001 (95\u202f% CI\u00a0\u22123.178 to\u00a0\u22121.519) and total morbidity RR=0.538, p&lt;0.001 (95\u202f% CI 0.395 to 0.731). Duration of surgery SMD=\u22120.0643 (95\u202f% CI\u00a0\u22120.993 to 0.865, p=0.892) and CC0 score RR=1.064 (95\u202f% CI 0.992 to 1.140, p=0.083) had no significant difference. Limited studies which evaluated survival showed similar outcomes. This meta-analysis shows that M-CRS and HIPEC\/EPIC is feasible and has better peri-operative outcomes compared to open procedure in patients with limited peritoneal carcinoma index (PCI) peritoneal surface malignancies. Survival outcomes were not calculated. Further studies are warranted in this regard.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2023-0017","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T15:10:33Z","timestamp":1710256233000},"page":"1-13","source":"Crossref","is-referenced-by-count":7,"title":["Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC\/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC\/EPIC in patients with peritoneal surface malignancies: a meta-analysis"],"prefix":"10.1515","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-9563","authenticated-orcid":false,"given":"Ajinkya","family":"Pawar","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology , 28979 GCRI , Ahmedabad , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Warikoo","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , 28979 GCRI , Ahmedabad , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Salunke","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , 28979 GCRI , Ahmedabad , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , 28979 GCRI , Ahmedabad , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Pandya","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , 28979 GCRI , Ahmedabad , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-8133","authenticated-orcid":false,"given":"Amol","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , 28979 GCRI , Ahmedabad , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"KS","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , 28979 GCRI , Ahmedabad , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-7228","authenticated-orcid":false,"given":"Jebin","family":"Aaron","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , 28979 GCRI , Ahmedabad , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"2025120909300622283_j_pp-2023-0017_ref_001","doi-asserted-by":"crossref","unstructured":"Go\u00e9r\u00e9, D, Malka, D, Tzanis, D, Gava, V, Boige, V, Eveno, C, et al.. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 2013;257:1065\u201371. https:\/\/doi.org\/10.1097\/SLA.0b013e31827e9289.","DOI":"10.1097\/SLA.0b013e31827e9289"},{"key":"2025120909300622283_j_pp-2023-0017_ref_002","doi-asserted-by":"crossref","unstructured":"Sugarbaker, PH. Peritonectomy procedures. Cancer Treat Res 2007;134:247\u201364. https:\/\/doi.org\/10.1007\/978-0-387-48993-3_15.","DOI":"10.1007\/978-0-387-48993-3_15"},{"key":"2025120909300622283_j_pp-2023-0017_ref_003","doi-asserted-by":"crossref","unstructured":"Jacquet, P, Sugarbaker, P. Peritoneal carcinomatosis: principles of management. Cancer treatment and research, Sugarbaker, P, editors. USA: Springer; 1996, vol 82:359\u201374 pp.","DOI":"10.1007\/978-1-4613-1247-5_23"},{"key":"2025120909300622283_j_pp-2023-0017_ref_004","doi-asserted-by":"crossref","unstructured":"Van der Speeten, K, Lemoine, L, Sugarbaker, P. Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. Pleura Peritoneum 2017;2:63\u201372. https:\/\/doi.org\/10.1515\/pp-2017-0003.","DOI":"10.1515\/pp-2017-0003"},{"key":"2025120909300622283_j_pp-2023-0017_ref_005","doi-asserted-by":"crossref","unstructured":"Canbay, E, Mizumoto, A, Ichinose, M, Ishibashi, H, Sako, S, Hirano, M, et al.. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Ann Surg Oncol 2014;21:1147\u201352. https:\/\/doi.org\/10.1245\/s10434-013-3443-2.","DOI":"10.1245\/s10434-013-3443-2"},{"key":"2025120909300622283_j_pp-2023-0017_ref_006","doi-asserted-by":"crossref","unstructured":"Deo, S, Ray, M, Bansal, B, Bhoriwal, S, Bhatnagar, S, Garg, R, et al.. Feasibility and outcomes of cytoreductive surgery and HIPEC for peritoneal surface malignancies in low- and middle-income countries: a single-center experience of 232 cases. World J Surg Oncol 2021;19:164. https:\/\/doi.org\/10.1186\/s12957-021-02276-5.","DOI":"10.1186\/s12957-021-02276-5"},{"key":"2025120909300622283_j_pp-2023-0017_ref_007","doi-asserted-by":"crossref","unstructured":"Foster, JM, Sleightholm, R, Patel, A, Shostrom, V, Hall, B, Neilsen, B, et al.. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open 2019;2:e186847. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6847.","DOI":"10.1001\/jamanetworkopen.2018.6847"},{"key":"2025120909300622283_j_pp-2023-0017_ref_008","doi-asserted-by":"crossref","unstructured":"H\u00fcbner, M, Kusamura, S, Villeneuve, L, Al-Niaimi, A, Alyami, M, Balonov, K, et al.. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) Society recommendations\u00a0\u2013 part I: preoperative and intraoperative management. Eur J Surg Oncol 2020;46:2292\u2013310. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.041.","DOI":"10.1016\/j.ejso.2020.07.041"},{"key":"2025120909300622283_j_pp-2023-0017_ref_009","doi-asserted-by":"crossref","unstructured":"H\u00fcbner, M, Kusamura, S, Villeneuve, L, Al-Niaimi, A, Alyami, M, Balonov, K, et al.. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) Society recommendations\u00a0\u2013 part II: postoperative management and special considerations. Eur J\u00a0Surg Oncol 2020;46:2311\u201323. https:\/\/doi.org\/10.1016\/j.ejso.2020.08.006.","DOI":"10.1016\/j.ejso.2020.08.006"},{"key":"2025120909300622283_j_pp-2023-0017_ref_010","doi-asserted-by":"crossref","unstructured":"Liu, ZH, Wang, N, Wang, FQ, Dong, Q, Ding, J. Oncological outcomes of laparoscopic versus open surgery in pT4 colon cancers: a systematic review and meta-analysis. Int J Surg 2018;56:221\u201333. https:\/\/doi.org\/10.1016\/j.ijsu.2018.06.032.","DOI":"10.1016\/j.ijsu.2018.06.032"},{"key":"2025120909300622283_j_pp-2023-0017_ref_011","doi-asserted-by":"crossref","unstructured":"Huang, C, Liu, H, Hu, Y, Sun, Y, Su, X, Cao, H, et al.. Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) group. laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: five-year outcomes from the CLASS-01 randomized clinical trial. JAMA Surg 2022;157:9\u201317. https:\/\/doi.org\/10.1001\/jamasurg.2021.5104.","DOI":"10.1001\/jamasurg.2021.5104"},{"key":"2025120909300622283_j_pp-2023-0017_ref_012","doi-asserted-by":"crossref","unstructured":"Uccella, S, Franchi, MP, Cianci, S, Zorzato, PC, Bertoli, F, Alletti, SG, et al.. Laparotomy vs. minimally invasive surgery for ovarian cancer recurrence: a systematic review. Gland Surg 2020;9:1130\u20139. https:\/\/doi.org\/10.21037\/gs-20-353.","DOI":"10.21037\/gs-20-353"},{"key":"2025120909300622283_j_pp-2023-0017_ref_013","doi-asserted-by":"crossref","unstructured":"van der Sluis, PC, van der Horst, S, May, AM, Schippers, C, Brosens, LAA, Joore, HCA, et al.. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg 2019;269:621\u201330. https:\/\/doi.org\/10.1097\/SLA.0000000000003031.","DOI":"10.1097\/SLA.0000000000003031"},{"key":"2025120909300622283_j_pp-2023-0017_ref_014","doi-asserted-by":"crossref","unstructured":"Kent, MS, Hartwig, MG, Valli\u00e8res, E, Abbas, AE, Cerfolio, RJ, Dylewski, MR, et al.. Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) study: an analysis of 5721 cases. Ann Surg 2023;277:528\u201333. https:\/\/doi.org\/10.1097\/SLA.0000000000005115.","DOI":"10.1097\/SLA.0000000000005115"},{"key":"2025120909300622283_j_pp-2023-0017_ref_015","doi-asserted-by":"crossref","unstructured":"Ciria, R, Cherqui, D, Geller, DA, Briceno, J, Wakabayashi, G. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann Surg 2016;263:761\u201377. https:\/\/doi.org\/10.1097\/sla.0000000000001413.","DOI":"10.1097\/SLA.0000000000001413"},{"key":"2025120909300622283_j_pp-2023-0017_ref_016","doi-asserted-by":"crossref","unstructured":"Esquivel, J, Averbach, A, Chua, TC. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience. Ann Surg 2011;253:764\u20138. https:\/\/doi.org\/10.1097\/SLA.0b013e31820784df.","DOI":"10.1097\/SLA.0b013e31820784df"},{"key":"2025120909300622283_j_pp-2023-0017_ref_017","doi-asserted-by":"crossref","unstructured":"Arjona-Sanchez, A, Esquivel, J, Glehen, O, Passot, G, Turaga, KK, Labow, D, et al.. A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: the American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis. Surg Endosc 2019;33:854\u201360. https:\/\/doi.org\/10.1007\/s00464-018-6352-4.","DOI":"10.1007\/s00464-018-6352-4"},{"key":"2025120909300622283_j_pp-2023-0017_ref_018","doi-asserted-by":"crossref","unstructured":"Arjona-Sanchez, A, Aziz, O, Passot, G, Salti, G, Esquivel, J, Van der Speeten, K, et al.. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry. Eur J Surg Oncol 2021;47:1420\u20136. https:\/\/doi.org\/10.1016\/j.ejso.2020.11.140.","DOI":"10.1016\/j.ejso.2020.11.140"},{"key":"2025120909300622283_j_pp-2023-0017_ref_019","doi-asserted-by":"crossref","unstructured":"Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","DOI":"10.1007\/s10654-010-9491-z"},{"key":"2025120909300622283_j_pp-2023-0017_ref_020","doi-asserted-by":"crossref","unstructured":"Moher, D, Liberati, A, Tetzlaff, J, Altman, DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264\u20139, W64. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135.","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"2025120909300622283_j_pp-2023-0017_ref_021","doi-asserted-by":"crossref","unstructured":"Chang, SC, Fingerhut, A, Chen, WT. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: propensity score-matched comparison between laparoscopy vs. open approaches. Surg Oncol 2022;43:101766. https:\/\/doi.org\/10.1016\/j.suronc.2022.101766.","DOI":"10.1016\/j.suronc.2022.101766"},{"key":"2025120909300622283_j_pp-2023-0017_ref_022","doi-asserted-by":"crossref","unstructured":"Cho, CY, Veerapong, J, Baumgartner, JM, Murphy, JD, Lowy, AM, Kelly, KJ. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis. Surg Endosc 2022. https:\/\/doi.org\/10.1007\/s00464-022-09589-w.","DOI":"10.1007\/s00464-022-09589-w"},{"key":"2025120909300622283_j_pp-2023-0017_ref_023","doi-asserted-by":"crossref","unstructured":"Fish, R, Selvasekar, C, Crichton, P, Wilson, M, Fulford, P, Renehan, A, et al.. Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique. Surg Endosc 2014;28:341\u20135. https:\/\/doi.org\/10.1007\/s00464-013-3189-8.","DOI":"10.1007\/s00464-013-3189-8"},{"key":"2025120909300622283_j_pp-2023-0017_ref_024","doi-asserted-by":"crossref","unstructured":"Abudeeb, H, Selvasekar, CR, O\u2019Dwyer, ST, Chakrabarty, B, Malcolmson, L, Renehan, AG, et al.. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms. Surg Endosc 2020;34:5516\u201321. https:\/\/doi.org\/10.1007\/s00464-019-07349-x.","DOI":"10.1007\/s00464-019-07349-x"},{"key":"2025120909300622283_j_pp-2023-0017_ref_025","doi-asserted-by":"crossref","unstructured":"Koti, S, Conte, C, Kadison, AB, Sullivan, JS, Wang, J, Zaidi, R, et al.. Enhanced postoperative recovery with minimally invasive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies of gastrointestinal origin. Surg Oncol 2020;33:38\u201342. https:\/\/doi.org\/10.1016\/j.suronc.2019.12.006.","DOI":"10.1016\/j.suronc.2019.12.006"},{"key":"2025120909300622283_j_pp-2023-0017_ref_026","doi-asserted-by":"crossref","unstructured":"Salti, GI, Naffouje, SA. Feasibility of hand-assisted laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy. Surg Endosc 2019;33:52\u20137. https:\/\/doi.org\/10.1007\/s00464-018-6265-2.","DOI":"10.1007\/s00464-018-6265-2"},{"key":"2025120909300622283_j_pp-2023-0017_ref_027","doi-asserted-by":"crossref","unstructured":"Mercier, F, Jeremie, G, Alyami, M, Delphine, V, Vahan, K, Pascal, R, et al.. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma. Surg Endosc 2020;34:4916\u201323. https:\/\/doi.org\/10.1007\/s00464-019-07280-1.","DOI":"10.1007\/s00464-019-07280-1"},{"key":"2025120909300622283_j_pp-2023-0017_ref_028","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Ortiz, L, Arjona-S\u00e1nchez, A, Iba\u00f1ez-Rubio, M, S\u00e1nchez-Hidalgo, J, Casado-Adam, A, Rufi\u00e1n-Pe\u00f1a, S, et al.. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. Surg Endosc 2021;35:1778\u201385. https:\/\/doi.org\/10.1007\/s00464-020-07572-x.","DOI":"10.1007\/s00464-020-07572-x"},{"key":"2025120909300622283_j_pp-2023-0017_ref_029","doi-asserted-by":"crossref","unstructured":"Passot, G, Bakrin, N, Isaac, S, Decullier, E, Gilly, FN, Glehen, O, et al.. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol 2014;40:957\u201362. https:\/\/doi.org\/10.1016\/j.ejso.2013.10.002.","DOI":"10.1016\/j.ejso.2013.10.002"},{"key":"2025120909300622283_j_pp-2023-0017_ref_030","doi-asserted-by":"crossref","unstructured":"Wang, C, Yin, XY, An, LB, Zhai, XC, Cai, Y, Shi, GJ, et al.. Significance of laparoscopic cytoreductive surgery for appendiceal pseudomyxoma peritonei with limited disease and low tumor burden. Asian J Surg 2023;46:1220\u20135. https:\/\/doi.org\/10.1016\/j.asjsur.2022.08.052.","DOI":"10.1016\/j.asjsur.2022.08.052"},{"key":"2025120909300622283_j_pp-2023-0017_ref_031","doi-asserted-by":"crossref","unstructured":"Fagotti, A, Costantini, B, Gallotta, V, Cianci, S, Ronsini, C, Petrillo, M, et al.. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes. J Minim Invasive Gynecol 2015;22:428\u201332. https:\/\/doi.org\/10.1016\/j.jmig.2014.11.008.","DOI":"10.1016\/j.jmig.2014.11.008"},{"key":"2025120909300622283_j_pp-2023-0017_ref_032","doi-asserted-by":"crossref","unstructured":"Park, SY, Choi, GS, Park, JS, Kim, HJ, Ryuk, JP, Yun, SH, et al.. Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy for patients with colorectal cancer peritoneal carcinomatosis: initial results from a single center. Surg Endosc 2014;28:1555\u201362. https:\/\/doi.org\/10.1007\/s00464-013-3351-3.","DOI":"10.1007\/s00464-013-3351-3"},{"key":"2025120909300622283_j_pp-2023-0017_ref_033","doi-asserted-by":"crossref","unstructured":"Ha, SH, Park, SY, Park, JS, Kim, HJ, Woo, IT, Park, IK, et al.. Short-term outcomes after laparoscopic cytoreductive surgery in patients with limited peritoneal metastases from colorectal cancer. Surgery 2019;165:775\u201381. https:\/\/doi.org\/10.1016\/j.surg.2018.09.017.","DOI":"10.1016\/j.surg.2018.09.017"},{"key":"2025120909300622283_j_pp-2023-0017_ref_035","doi-asserted-by":"crossref","unstructured":"Cort\u00e9s-Guiral, D, H\u00fcbner, M, Alyami, M, Bhatt, A, Ceelen, W, Glehen, O, et al.. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers 2021;7:91. https:\/\/doi.org\/10.1038\/s41572-021-00326-6.","DOI":"10.1038\/s41572-021-00326-6"},{"key":"2025120909300622283_j_pp-2023-0017_ref_036","doi-asserted-by":"crossref","unstructured":"Ray, MD, Dhall, K. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the management of peritoneal surface malignancies\u00a0\u2013 an evidence-based review. Curr Probl Cancer 2021;45:100737. https:\/\/doi.org\/10.1016\/j.currproblcancer.2021.100737.","DOI":"10.1016\/j.currproblcancer.2021.100737"},{"key":"2025120909300622283_j_pp-2023-0017_ref_037","doi-asserted-by":"crossref","unstructured":"Brandl, A, Zielinski, CB, Raue, W, Pratschke, J, Rau, B. Peritoneal metastases of rare carcinomas treated with cytoreductive surgery and HIPEC\u00a0\u2013 a single center case series. Ann Med Surg 2017;22:7\u201311. https:\/\/doi.org\/10.1016\/j.amsu.2017.08.009.","DOI":"10.1016\/j.amsu.2017.08.009"},{"key":"2025120909300622283_j_pp-2023-0017_ref_038","unstructured":"Newton, AD, Bartlett, EK, Karakousis, GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol 2016;7:99\u2013111. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.100."},{"key":"2025120909300622283_j_pp-2023-0017_ref_039","doi-asserted-by":"crossref","unstructured":"Jingli, C, Rong, C, Rubai, X. Influence of colorectal laparoscopic surgery on dissemination and seeding of tumor cells. Surg Endosc 2006;20:1759\u201361. https:\/\/doi.org\/10.1007\/s00464-005-0694-4.","DOI":"10.1007\/s00464-005-0694-4"},{"key":"2025120909300622283_j_pp-2023-0017_ref_040","doi-asserted-by":"crossref","unstructured":"Polymeneas, G, Theodosopoulos, T, Stamatiadis, A, Kourias, E. A comparative study of postoperative adhesion formation after laparoscopic vs open cholecystectomy. Surg Endosc 2001;15:41\u20133. https:\/\/doi.org\/10.1007\/s004640000269.","DOI":"10.1007\/s004640000269"},{"key":"2025120909300622283_j_pp-2023-0017_ref_041","unstructured":"Tentes, AA, Pallas, N, Korakianitis, O, Mavroudis, C, Spiridonidou, A, Zorbas, G, et al.. The cost of cytoreductive surgery and perioperative intraperitoneal chemotherapy in the treatment of peritoneal malignancy in one Greek institute. J BUON 2012;17:776\u201380."},{"key":"2025120909300622283_j_pp-2023-0017_ref_042","doi-asserted-by":"crossref","unstructured":"Simkens, GA, Rovers, KP, van Oudheusden, TR, Nienhuijs, SW, Rutten, HJ, de Hingh, IH. Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases. Medicine 2018;97:e0042. https:\/\/doi.org\/10.1097\/MD.0000000000010042.","DOI":"10.1097\/MD.0000000000010042"},{"key":"2025120909300622283_j_pp-2023-0017_ref_043","doi-asserted-by":"crossref","unstructured":"Becerra, AZ, Aquina, CT, Mohile, SG, Tejani, MA, Schymura, MJ, Boscoe, FP, et al.. Variation in delayed time to adjuvant chemotherapy and disease-Specific survival in stage III colon cancer patients. Ann Surg Oncol 2017;24:1610\u201317. https:\/\/doi.org\/10.1245\/s10434-016-5622-4.","DOI":"10.1245\/s10434-016-5622-4"},{"key":"2025120909300622283_j_pp-2023-0017_ref_044","doi-asserted-by":"crossref","unstructured":"Gamboa, AC, Lee, RM, Turgeon, MK, Zaidi, MY, Kimbrough, CW, Grotz, TE, et al.. Implications of postoperative complications for survival after cytoreductive surgery and HIPEC: a multi-institutional analysis of the US HIPEC collaborative. Ann Surg Oncol 2020;27:4980\u201395. https:\/\/doi.org\/10.1245\/s10434-020-08843-6.","DOI":"10.1245\/s10434-020-08843-6"},{"key":"2025120909300622283_j_pp-2023-0017_ref_045","doi-asserted-by":"crossref","unstructured":"Pomel, C, Appleyard, TL, Gouy, S, Rouzier, R, Elias, D. The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005;31:540\u20133. https:\/\/doi.org\/10.1016\/j.ejso.2005.01.009.","DOI":"10.1016\/j.ejso.2005.01.009"},{"key":"2025120909300622283_j_pp-2023-0017_ref_046","doi-asserted-by":"crossref","unstructured":"Kelly, KJ, Baumgartner, JM, Lowy, AM. Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei. Ann Surg Oncol 2015;22:1722\u20135. https:\/\/doi.org\/10.1245\/s10434-014-4118-3.","DOI":"10.1245\/s10434-014-4118-3"},{"key":"2025120909300622283_j_pp-2023-0017_ref_047","doi-asserted-by":"crossref","unstructured":"Ferron, G, Gesson-Paute, A, Classe, JM, Querleu, D. Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: an experimental study. Gynecol Oncol 2005;99:358\u201361. https:\/\/doi.org\/10.1016\/j.ygyno.2005.06.043.","DOI":"10.1016\/j.ygyno.2005.06.043"},{"key":"2025120909300622283_j_pp-2023-0017_ref_034","doi-asserted-by":"crossref","unstructured":"Clavien, PA, Barkun, J, de Oliveira, ML, Vauthey, JN, Dindo, D, Schulick, RD, et al.. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187\u201396. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2.","DOI":"10.1097\/SLA.0b013e3181b13ca2"},{"key":"2025120909300622283_j_pp-2023-0017_ref_048","doi-asserted-by":"crossref","unstructured":"van der Pas, MH, Haglind, E, Cuesta, MA, F\u00fcrst, A, Lacy, AM, Hop, WC, et al.; COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14:210\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(13)70016-0.","DOI":"10.1016\/S1470-2045(13)70016-0"},{"key":"2025120909300622283_j_pp-2023-0017_ref_049","doi-asserted-by":"crossref","unstructured":"Kang, SB, Park, JW, Jeong, SY, Nam, BH, Choi, HS, Kim, DW, et al.. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010;11:637\u201345. https:\/\/doi.org\/10.1016\/S1470-2045(10)70131-5.","DOI":"10.1016\/S1470-2045(10)70131-5"},{"key":"2025120909300622283_j_pp-2023-0017_ref_050","doi-asserted-by":"crossref","unstructured":"Gueli Alletti, S, Bottoni, C, Fanfani, F, Gallotta, V, Chiantera, V, Costantini, B, et al.. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study. Am J Obstet Gynecol. 2016;214:503.e1\u2013e6. https:\/\/doi.org\/10.1016\/j.ajog.2015.10.922.","DOI":"10.1016\/j.ajog.2015.10.922"},{"key":"2025120909300622283_j_pp-2023-0017_ref_051","doi-asserted-by":"crossref","unstructured":"Petrillo, M, Zucchetti, M, Cianci, S, Morosi, L, Ronsini, C, Colombo, A, et al.. Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study. J Gynecol Oncol 2019;30:e59. https:\/\/doi.org\/10.3802\/jgo.2019.30.e59.","DOI":"10.3802\/jgo.2019.30.e59"},{"key":"2025120909300622283_j_pp-2023-0017_ref_052","doi-asserted-by":"crossref","unstructured":"Gesson-Paute, A, Ferron, G, Thomas, F, de Lara, EC, Chatelut, E, Querleu, D. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol 2008;15:339\u201344. https:\/\/doi.org\/10.1245\/s10434-007-9571-9.","DOI":"10.1245\/s10434-007-9571-9"},{"key":"2025120909300622283_j_pp-2023-0017_ref_053","doi-asserted-by":"crossref","unstructured":"Facy, O, Al Samman, S, Magnin, G, Ghiringhelli, F, Ladoire, S, Chauffert, B, et al.. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study. Ann Surg 2012;256:1084\u20138. https:\/\/doi.org\/10.1097\/SLA.0b013e3182582b38.","DOI":"10.1097\/SLA.0b013e3182582b38"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2023-0017\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2023-0017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:07:41Z","timestamp":1765278461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2023-0017\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2,28]]},"published-print":{"date-parts":[[2024,3,30]]}},"alternative-id":["10.1515\/pp-2023-0017"],"URL":"https:\/\/doi.org\/10.1515\/pp-2023-0017","relation":{},"ISSN":["2364-768X"],"issn-type":[{"value":"2364-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}